Viewing StudyNCT02570542



Ignite Creation Date: 2024-05-06 @ 7:40 AM
Last Modification Date: 2024-10-26 @ 11:50 AM
Study NCT ID: NCT02570542
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2023-11-13
First Post: 2015-10-05

Brief Title: Study of the Impact of CD34 Cell Dose on Absolute Lymphocyte Count Following High-Dose Therapy and Autologous Stem Cell Transplantation for Relapsed and Refractory Diffuse Large B-cell Lymphoma DLBCL
Sponsor: Memorial Sloan Kettering Cancer Center
Organization: Memorial Sloan Kettering Cancer Center

Organization Data

Organization: Memorial Sloan Kettering Cancer Center
Class: OTHER
Study ID: 15-193
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Memorial Sloan Kettering Cancer Center
Lead Sponsor Class: OTHER
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
University Hospitals Seidman Cancer Center OTHER
Columbia University OTHER
NorthShore University HealthSystem OTHER
University of Rochester OTHER
Medical College of Wisconsin OTHER
University of Nebraska OTHER
Sanofi INDUSTRY